The QualityStocks Daily Wednesday, July 24th, 2024

Today's Top 3 Investment Newsletters

QualityStocks(NUZE) $3.3500 +225.24%

Premium Stock Alerts(SLNA) $0.0457 +75.77%

SeriousTraders(NTRB) $9.2500 +19.51%

The QualityStocks Daily Stock List

NuZee Inc. (NUZE)

QualityStocks, StocksEarning, MarketClub Analysis, TradersPro, The Stock Dork, Prism MarketView, PennyStockProphet and Money Wealth Matters reported earlier on NuZee Inc. (NUZE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

NuZee Inc. (NASDAQ: NUZE) (FRA: 5UQ) is a specialty coffee firm that is focused on manufacturing, packing, marketing and selling of tea bag-style coffee and single serve coffee for suppliers and roasters.

The firm has its headquarters in Plano, Texas and was incorporated in 2011, on November 9th. It operates as part of the packaged foods industry, under the consumer retail sector. The firm has two companies in its corporate family and serves consumers around the globe, with a focus on South Korea, Japan and North America.

The company is building proprietary coffee brands that provide nutritional and functional benefits. It leverages the position it has as a co-packer at the forefront of the pour-over single-serve coffee market in North America to transform single-serve coffee enjoyed in America. The company’s geographical segments are South Korea, Japan and North America, which generates most of its revenue.

The enterprise co-packs products, producing and selling them directly to consumers. Its single-serve products are portable and have several consume-later applications that aren’t available to machine-based solutions like office, travel and camping. Its single serve products target the individual customer for use in the office or at home. Its brand portfolio includes Pine Ranch, Twin Peaks and Coffee Blenders.

The firm is focused on expanding its manufacturing footprint to the Eastern region of the United States. This will not only allow the firm to improve the efficiency of its logistics but also enable it to better serve its consumers, which will positively influence the firm’s revenues while also bolstering its growth significantly.

NuZee Inc. (NUZE), closed Wednesday's trading session at $3.35, up 225.2427%, on 135,839,904 volume. The average volume for the last 3 months is 1.157M and the stock's 52-week low/high is $1.01/$12.39.

Dermata Therapeutics (DRMA)

QualityStocks, The Stock Dork, MarketBeat and InvestorsUnderground reported earlier on Dermata Therapeutics (DRMA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Dermata Therapeutics Inc. (NASDAQ: DRMA) is a clinical-stage biotechnology firm that is focused on treating aesthetic and medical skin conditions.

The firm has its headquarters in San Diego, California and was incorporated in December 2014 by Gerald T. Proehl and David F. Hale. The firm serves consumers around the globe.

The company believes it has the potential to address various facets of psoriasis vulgaris, acne rosacea, acne vulgaris and other multiple aesthetic areas with high unmet clinical needs. Its business strategy is to identify and develop innovative products that can be moved into clinical trials to demonstrate their safety and effectiveness in treating various indications.

The enterprise’s product portfolio is comprised of product candidates it has developed using its Spongilla platform technology. The technology is based on the use of Songillalacustris, a freshwater sponge which naturally grows in lakes and rivers in commercial quantities in different parts of the globe. The enterprise’s candidates include a once-a-week topical formulation dubbed DMT310, which is under clinical development and is indicated for the treatment of papulopustular rosacea, psoriasis vulgaris and acne vulgaris. It also develops a formulation dubbed DMT410, for the treatment of various aesthetic conditions like hyperhidrosis.

The firm recently announced its latest financial results, with its CEO noting that they were focused on advancing the firm’s clinical pipeline for multiple indications having released positive topline results from its DMT310 clinical trial. The success and approval of the firm’s formulations will bring in additional revenue as well as investors, which will be good for its growth.

Dermata Therapeutics (DRMA), closed Wednesday's trading session at $2.67, up 105.3846%, on 65,307,983 volume. The average volume for the last 3 months is 1.07M and the stock's 52-week low/high is $1.29/$23.6985.

Shimmick (SHIM)

Premium Stock Alerts, MarketBeat and QualityStocks reported earlier on Shimmick (SHIM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Shimmick Corp. (NASDAQ: SHIM) is a company engaged in the provision of water and other critical infrastructure solutions.

The firm has its headquarters in Irvine, California and was incorporated in 1990. It operates as part of the engineering and construction industry, under the industrials sector. The firm serves consumers in the United States.

The company is at the forefront of delivering solutions to meet the nation’s growing demand for water infrastructure. Its commitment extends to water treatment, water conveyance, water storage, flood protection, environmental projects, and more.

Shimmick focuses on different types of infrastructure projects, including water treatment, water resources, and other critical infrastructure. It expands, rehabilitates, upgrades, builds, and rebuilds water and wastewater treatment infrastructure, including desalination plants. It implements cleantech treatment technologies including ozonation, biologically activated carbon, membrane filtration, reverse osmosis, chemical treatment, and oxidation. It also builds, expands, and enhances water storage and conveyance, including dams, levees, flood control systems, pump stations, and coastal protection. In addition to this, the enterprise upgrades and expands locks and dams along its waterways to enable continued emission-reduced movement of goods. Furthermore, it builds, retrofits, expands, rehabilitates, operates, and maintains its critical infrastructure, including mass transit, bridges, and military infrastructure.

The firm recently signed a $27,583,595 subcontract for electrical work on the Sunol Valley Water Treatment Plant Ozonation project. This project shall significantly improve water quality for millions of Bay Area residents while also opening the firm up to new growth and investment opportunities to help generate additional value for its shareholders.

Shimmick (SHIM), closed Wednesday's trading session at $3.16, up 1.9355%, on 243,164 volume. The average volume for the last 3 months is 2.234M and the stock's 52-week low/high is $1.4705/$7.99.

Richtech Robotics (RR)

Profit Confidential, Stockhouse and Premium Stock Alerts reported earlier on Richtech Robotics (RR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Richtech Robotics Inc. (NASDAQ: RR) is a company focused on developing, manufacturing, deploying, and selling advanced robotic technologies for labor-intensive services in the service industry.

The firm has its headquarters in Las Vegas, Nevada and was incorporated in 2016. Prior to its name change on June 22nd, 2022, the firm was known as Richtech Creative Displays LLC. It operates as part of the specialty industrial machinery industry, under the industrials sector. The firm serves consumers around the globe.

The enterprise designs, manufactures and sells robots to restaurants, hotels, senior living centers, casinos, factories, movie theatres and other businesses. Its robots are designed to be friendly, customizable to client environments, and extremely reliable. They perform a range of services, including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The enterprise’s AI Cloud Platform (ACP) allows businesses to plug in their robots and immediately leverage an immense amount of data to optimize workflows, lower management complexity, and minimize labor dependency. Its products are categorized into three kinds of service automation: indoor transport and delivery, sanitation, and food and beverage automation. The enterprise's robots include ADAM, Richie, ARM, DUST-E MX, Matradee DUST-E SX, Matradee L, and Matradee X, among others.

The company recently launched a new robot dubbed Medbot, to help streamline pharmacy operations with uninterrupted, 24/7 medications delivery. This furthers Richtech Robotics’ mission of providing high-quality, stable robots to improve clients’ bottom line and boost employee morale. This is in addition to affording hospitals a competitive edge.

Richtech Robotics (RR), closed Wednesday's trading session at $1.14, off by 2.5641%, on 2,823,318 volume. The average volume for the last 3 months is 45.436M and the stock's 52-week low/high is $1.05/$12.29.

Palantir Technologies Inc. (PLTR)

Kiplinger Today, Schaeffer's, InvestorPlace, MarketClub Analysis, INO Market Report, StockEarnings, MarketBeat, The Street, Early Bird, StocksEarning, Zacks, Trades Of The Day, Daily Trade Alert, Top Pros' Top Picks, The Online Investor, StreetInsider, InvestorsUnderground, The Night Owl, Cabot Wealth, QualityStocks, The Wealth Report, FreeRealTime, Investopedia, Investment House, Smart Investing Society, CNBC Breaking News, Earnings360, DividendStocks, TradersPro, AllPennyStocks, Smartmoneytrading, Prism MarketView, INO Traders Blog, bullseyeoptiontrading, InsiderTrades, Investors Underground, Lance Ippolito, 360wallstreet, OTC Stock Review, Rick Saddler, The Stock Dork, Tim Bohen, TradeSmith Daily, Uptick Daily, Wealth Insider Alert, wyatt research newsletter and Money Morning reported earlier on Palantir Technologies Inc. (PLTR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

This past spring, Google rolled out a feature that enabled answers from its artificial intelligence (AI) chatbot to begin appearing above normal search results, even for questions related to health issues. While this might seem like a good idea on paper, some concerns have been raised about the health advice provided by this AI overview feature.

About a week after the bot’s launch, a quick search saw Google AI recommend that individuals eat at least a small rock daily for minerals and vitamins. It was later determined that this answer was retrieved from a satirical post. Another user revealed that the search engine gave incorrect and potentially fatal information on what to do if an individual was bitten by a rattlesnake.

These issues come as software designers continue to test whether chatbots powered by AI can accurately give medical advice.

Google has since removed these inaccurate search results and restricted the inclusion of humor and satirical sites in its AI Overview. In a statement, a Google spokesperson explained that the majority of overviews offered high-quality data, noting that strong safety and quality guardrails were in place for health queries. These included disclaimers reminding individuals of the importance of seeking expert advice.

The spokesperson then noted that the company was focused on ensuring information provided in search results was reliable and of high quality.

Confirmation by CBS News notes that these fixes haven’t completely eliminated misinformation, however; one question asked when infants should begin eating solid food, and the bot gave “under six months” as its solution. This is wrong as infants aren’t supposed to start eating solid food until they hit at least six months.

Despite these errors, many leaders in the healthcare sector are optimistic about these AI-powered bots and how they can impact the industry. Stanford Healthcare chief data scientist, Dr. Nigam Shah, explains that this technology allows individuals to access the information they need. Shah notes that while he’s pessimistic about their use in the short-term, he expects the technologies to do a lot of good in the long-term.

The World Health Organization has already ventured into the artificial intelligence space with the launch of its chatbot, Sarah. Sarah obtains data from the organization’s website and trusted partners, which greatly reduces the risk of errors when providing answers to users. When asked how to reduce the risk of a heart attack, Sarah provided information on sleeping well, stress management and maintaining a healthy lifestyle.

Generally, it is expected that advancements in oversight and design will improve the performance of these bots.

The issue of bot accuracy is something that all players in the AI space, including Palantir Technologies Inc. (NYSE: PLTR), need to ensure because inaccuracies could derail customer confidence.

Palantir Technologies Inc. (PLTR), closed Wednesday's trading session at $26.6, off by 7.6709%, on 49,004,105 volume. The average volume for the last 3 months is 833,600 and the stock's 52-week low/high is $13.68/$29.83.

Cresco Labs Inc. (CRLBF)

QualityStocks, InvestorPlace, Kiplinger Today, Daily Trade Alert, MarketBeat, Cabot Wealth, Top Pros' Top Picks, The Street, The Wealth Report, Wealth Insider Alert, Trading For Keeps, Trades Of The Day, CannabisNewsWire, The Online Investor, Early Bird, Prism MarketView, StreetInsider, wyatt research newsletter, TradersPro and StocksEarning reported earlier on Cresco Labs Inc. (CRLBF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Cannabis Regulators Association (CANNRA) is requesting that the U.S. Drug Enforcement Administration and Biden Administration offer clarity on how rescheduling cannabis will affect enforcement by the federal government, particularly in legal states. In a public comment to the DEA’s administrator Anne Milgram, CANNRA leaders explained that without federal guidance, territorial and state government agencies would be left guessing and hypothesizing about these dynamics and their possible effects on legal programs regulated by states, and the populations impacted by these programs in various jurisdictions, among other things.

CANNRA is an organization that represents hemp and cannabis regulators in more than 45 states and territories in the United States. This nonpartisan organization doesn’t make a stand on the proposal to reschedule the drug but rather, seeks guidance on how the change will impact enforcement priorities, policies, and interactions with local and state officials.

CANNRA also stressed its commitment to supporting its members in the successful implementation of the final regulation on rescheduling. The proposal to reschedule cannabis at the federal level was officially announced in May, with the public comment period coming to an end on July 22, 2024.

In its statement, CANNRA also highlighted areas where guidance related to the drug’s rescheduling was necessary. Apart from its impact on federal enforcement priorities, guidance on requirements and allowance for interstate commerce under the new classification was needed.

The organization noted that it would be important to offer clarity on how marijuana’s rescheduling would impact banking for the marijuana industry as well as current hindrances to research on cannabis. Further federal guidance would also be needed on how cannabinoids would be regulated under the new schedule.

In other news, bipartisan legislators are working to eliminate a section of a spending measure that would block the U.S. Department of Justice from rescheduling cannabis. Representative Nancy Mace revealed last week that she was focused on ensuring rescheduling happens, even though she was more in favor of the drug being fully descheduled.

A similar amendment to the Commerce, Justice, Science and Related Agencies spending resolution was introduced in the House by Representative Rashida Tlaib.

Despite this progress, Republican lawmakers are still trying to block the Biden administration from rescheduling marijuana. Earlier this month, a group of GOP legislators penned a letter discussing their stance against rescheduling the drug. The letter claimed that the proposal wasn’t based on science but on politics.

Senator James Lankford and Representative Pete Sessions led this charge, with the letter being signed by 23 other Senate and House Republican congressional legislators.

This clarity that the state regulators are seeking would also be of great help to marijuana companies such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) since their operations or plans may need to change in light of the change in federal cannabis classification.

Cresco Labs Inc. (CRLBF), closed Wednesday's trading session at $1.64, off by 5.4374%, on 327,492 volume. The average volume for the last 3 months is 46.167M and the stock's 52-week low/high is $1.00/$2.77.

Rivian Automotive Inc. (RIVN)

Schaeffer's, InvestorPlace, QualityStocks, The Street, Kiplinger Today, MarketClub Analysis, MarketBeat, Early Bird, StockEarnings, INO Market Report, Investopedia, The Online Investor, Zacks, GreenCarStocks, Daily Trade Alert, Louis Navellier, AllPennyStocks, TipRanks, Trades Of The Day, StocksEarning, The Night Owl, BillionDollarClub, InvestorIntel, DividendStocks, InvestorsUnderground, Cabot Wealth, FreeRealTime, 360 Wall Street, Premium Stock Alerts, Hit and Run Candle Sticks, Top Pros’ Top Picks, Rick Saddler, bullseyeoptiontrading, Investors Underground and Top Pros' Top Picks reported earlier on Rivian Automotive Inc. (RIVN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

California’s goal of installing one million public electric vehicle charging stations by the end of the decade to support mass EV adoption may be unrealistic and unattainable, some experts say. As the state with the highest number of battery electric vehicles (BEVs) in the country, California is already home to a large portion of North America’s public EV charging infrastructure. However, the state will need at least a million charging stations by 2030 to support its growing EV market, giving California only seven years to achieve this goal.

A growing number of experts say California will have to install public EV chargers at an unprecedented rate to meet its public-charging infrastructure goals by 2030, let alone doubling it to two million stations by 2035. While the goals are admirable and necessary to help California support the seven million electric vehicles expected to be on its roads by the end of the decade, some experts say the goals are unrealistic.

Limited charging infrastructure is already a major problem across the continental United States and is one of the main reasons why many drivers aren’t willing to go electric. Even California struggles to adequately serve its electric vehicle drivers as the charging infrastructure tends to be concentrated in certain urbanized regions. The state now has to increase its charging stations from around 100,000 to a million in the next seven years, a feat that will require 129,000 new charging stations every year to achieve.

Furthermore, California has to ramp up this pace once 2030 hits to allow it to build another million chargers in only five years, bringing the total to 2.1 million public-electric-vehicle chargers by 2035. This should leave the state with a robust network of public chargers that can alleviate customer fears of range anxiety and comfortably support more than seven million battery electric cars. Stanford University professor Bruce Cain argues that it is “very unlikely” California will achieve this goal and even states that California’s electrification goals are “noble but unrealistic.”

Cain called on state leaders to deal with potential policy and institutional obstacles before “blindly” committing to ambitious goals. Many lawmakers and industry experts are also worried that California won’t be able to carry out such a large-scale project in a decade and may be unable to support its growing electric-vehicle market.

One of the key factors that will likely hinder the achievement of these ambitious goals is cost; one fast charger costs an estimated $120,000 or even more to install. Installing up to two million chargers will be a massive financial undertaking that will require major funding from the state government as well as private investors.

The project will also require major upgrades to California’s power grid, streamlined permitting processes from counties to cities, and increased efforts to connect public EV chargers to the state grid. Ensuring that even less affluent and rural areas have equitable access to the public charging network by encouraging private companies to invest in these regions will also prove to be a challenge.

While local, state and the federal governments can play a crucial role in ensuring that sufficient charging facilities are created, individual companies such as Rivian Automotive Inc. (NASDAQ: RIVN) also have a responsibility to contribute to this effort since buyers will scrutinize which companies have reliable charging infrastructure before making a buying decision. This is partly why Tesla has been dominant in the industry, due to its supercharger network.

Rivian Automotive Inc. (RIVN), closed Wednesday's trading session at $16.27, off by 7.0286%, on 38,344,424 volume. The average volume for the last 3 months is 9.036M and the stock's 52-week low/high is $8.26/$28.06.

Hecla Mining Company (HL)

MarketClub Analysis, QualityStocks, Schaeffer's, SmarTrend Newsletters, InvestorPlace, StocksEarning, Wyatt Investment Research, MarketBeat, Lebed.biz, Top Pros' Top Picks, DividendStocks, TopStockAnalysts, StockEarnings, StreetAuthority Daily, The Street, INO.com Market Report, Zacks, Money Morning, Marketbeat.com, Jason Bond, Daily Trade Alert, Kiplinger Today, MiningNewsWire, Wall Street Grand, StreetInsider, Today's Financial News, Trades Of The Day, TradersPro, StockOodles, INO Market Report, Streetwise Reports, TheStockAdvisors, The Wealth Report, Gryphon Digest, Stockhouse, Penny Detectives, SureMoney, TradingAuthority Daily, Early Bird, National Inflation Association, Darwin Investing Network, ChartAdvisor, Options Elite, PennyStockLive, Penny Sleuth, Profit Confidential, ProfitableTrading, Wall Street Daily, TraderPower, The Growth Stock Wire, Daily Markets, Traders For Cash Flow, Greenbackers, FreeRealTime, Forbes, TradingMarkets, DrStockPick, Wealth Insider Alert, WealthMakers, Investing Lab, CustomerService, CRWEWallStreet, CRWEPicks, CRWEFinance, Weiss Research, BestOtc, Barchart, Daily Wealth, StockHotTips, AllPennyStocks, PennyToBuck, MonsterStocksPicks, Money and Markets, Residual Income Report, Rockwell Trading, SmallCapVoice, Trade of the Week, Stock Stars, PennyOmega, The Online Investor, InvestorIntel, InvestorGuide, Investor Update, Investor Guide, Investopedia, Investing Futures and MarketArmor.com reported earlier on Hecla Mining Company (HL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Silver is a precious metal that is highly traded by investors. Historically, the metal has been used as a medium of exchange and a store of value. While the metal is less popular in comparison to gold, traders often turn to it due to its intrinsic value to diversify their portfolios. The metal can also be a potential hedge in times of high inflation.

Last week, the price of silver dropped to $30.06 and showed signs of recovery soon after, hinting at an increase that could see the metal’s price potentially reach the $32.00 mark. The metal’s highest price is $32.33 an ounce, set earlier in May this year.

This comes as one survey determined that silver spot prices performed better than gold thus far this year. The data showed that silver’s spot prices rose by nearly 40% in the first six months of this year, driven mainly by an increase in global demand for silver and U.S. expectations of interest rate cuts.

First Majestic Silver CEO, Keith Neumeyer, believes that the metal’s price may go even higher, even reaching the $100 mark. Neumeyer has voiced this opinion for a couple of years now, explaining that silver’s undervaluing, consistent deficit and industrial demand will drive the increase in price.

The recent bounce back has sparked investor interest, as some work to exploit the volatility in the metal’s market. Despite this, the Fed’s policy decisions still have great influence over future movements in price, especially when it comes to rates of inflation.

High inflation may increase the price of silver while devaluing the dollar. While the current $32 high may seem attractive to investors, active management of one’s portfolio and added vigilance are advised as precautionary measures. Investors are also advised to keep in mind that the metal’s market can be influenced by external factors, such as a range of macroeconomic factors and geopolitical tensions. To temper this, investors are urged to maintain a diverse portfolio to help soften the impact of any uncertainties that may arise.

Additionally, investors are directed to focus on their long-term investment strategies and avoid impulsive decisions based on sudden fluctuations. Investors can buy physical silver in bullion or in coins, or trade it via vehicles such as ETFs. Silver stocks, such as Hecla Mining Company (NYSE: HL) and other major producers, and futures contracts are other ways to invest in silver. It should be noted that investing in the financial market always carries risks. This makes the need for professional advice as well as due diligence on the investor’s part important.

Hecla Mining Company (HL), closed Wednesday's trading session at $5.88, off by 1.0101%, on 7,479,057 volume. The average volume for the last 3 months is 520,334 and the stock's 52-week low/high is $3.33/$6.35.

Stronghold Digital Mining Inc. (SDIG)

QualityStocks, RedChip, MarketBeat, Investor News, InvestorPlace, Real Pennies, SmallCapVoice, StockEarnings, Zacks, CryptoCurrencyWire, OTC Markets Group, StockPicksNYC, StocksEarning, The Online Investor, InsiderTrades, Early Bird and Prism MarketView reported earlier on Stronghold Digital Mining Inc. (SDIG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Europe is the most popular region for cryptocurrency trading, accounting for 37.32% of global transaction value, according to a thorough investigation by Coinwire. This prominent position is largely due to Europe’s tech-savvy populace and forward-thinking regulatory frameworks, making it a prime spot for cryptocurrency investments and advancements.

Asia trails behind Europe, contributing 36.17% to global crypto transaction values. Asia’s substantial trading volumes are driven by widespread mobile use, a strong tech infrastructure and increasing interest from institutional investors.

The analysis anticipates Europe’s crypto trading volume to soar to $40.5 trillion in 2024, a significant jump from $15 trillion in 2022, marking a 2.7-fold increase.

Europe is highly proactive in shaping its crypto industry through clear regulations. These rules help authorities understand fintech better and provide clear guidelines for exchanges and traders as they navigate the market. A key regulation in the European Union is the Markets in Crypto-Assets (MiCA) Regulation, which started enforcing its first set of regulations on June 30, 2024, and is primarily focused on stablecoins. Further regulations for cryptocurrency asset service providers are expected to roll out in December this year.

Delving into Europe’s expected $40.5 trillion trading volume, Russia stands out as the leading country, with a volume surpassing $633 billion. The United Kingdom’s $624 billion in trade volume places it sixth internationally and second in Europe. Despite the ongoing war, Ukraine holds the third spot with a trading volume of about $442 billion. Notably, the amount of money that Ukrainians invest in cryptocurrencies is almost three times their monthly rent, a sign of strong trading volumes compared to average income.

Slovenia, with just over two million people, has the most trading volume per internet user in Europe. According to the analysis, Slovenians have a strong belief in digital assets and supportive policies, as evidenced by their monthly average expenditure of $2,609 on cryptocurrency, which is more than almost four times their monthly rent.

Turkey and India are the world’s second- and third-ranked countries, respectively, with trading volumes above $1 trillion. The United States leads the pack, with trading volumes exceeding $2 trillion.

In the exchange market, Binance emerged as the most influential and popular exchange worldwide, with $2.77 trillion in trading volume. The exchange recently commemorated both its seventh anniversary and reaching 200 million users globally. Other notable exchanges are CEX.IO and OKX, which are present in 92 and 93 countries, respectively, and with trade volumes of $1.83 billion and $759 billion.

The figures above highlighting how different markets are progressing in terms of crypto uptake could serve as eye-openers for entities such as Stronghold Digital Mining Inc. (NASDAQ: SDIG) in terms of potential sources of investment that they can target in their marketing efforts.

Stronghold Digital Mining Inc. (SDIG), closed Wednesday's trading session at $3.5, off by 8.8542%, on 1,397,713 volume. The average volume for the last 3 months is 98.506M and the stock's 52-week low/high is $1.65/$11.56.

Tesla Inc. (TSLA)

The Street, Green Car Stocks, InvestorPlace, StreetInsider, Schaeffer's, Kiplinger Today, Investopedia, Zacks, MarketClub Analysis, MarketBeat, The Online Investor, Daily Trade Alert, Money Morning, Options Elite, StreetAuthority Daily, Trades Of The Day, Early Bird, Market Intelligence Center Alert, Cabot Wealth, Energy and Capital, All about trends, StocksEarning, Wealth Daily, CNBC Breaking News, TopStockAnalysts, InvestorGuide, Uncommon Wisdom, Barchart, StockEarnings, The Motley Fool, Louis Navellier, Street Insider, MarketWatch, Daily Profit, Profit Confidential, Marketbeat.com, Trading Tips, AllPennyStocks, Money and Markets, Top Pros' Top Picks, ProfitableTrading, Investors Alley, InvestorIntel, Alternative Energy, Money Wealth Matters, SmarTrend Newsletters, INO Market Report, TipRanks, Wyatt Investment Research, Wealth Insider Alert, StrategicTechInvestor, Investor Guide, Wall Street Daily, The Wealth Report, Investing Daily, Greenbackers, FreeRealTime, Market Intelligence Center, CustomerService, Investment U, smartmoneytrading, MarketTamer, The Street Report, Stock Up Featured, QualityStocks, Daily Wealth, Wall Street Elite, INO.com Market Report, Trading Concepts, Hit and Run Candle Sticks, wyatt research newsletter, Eagle Financial Publications, Investiv, National Inflation Association, The Growth Stock Wire, SureMoney, Jon Markman’s Pivotal Point, StockMarketWatch, Investing Futures, Short Term Wealth, GorillaTrades, Wall Street Profit Search, Streetwise Reports, DividendStocks, Insider Wealth Alert, Market Authority, Darwin Investing Network, Investment House, equities Canada, Stock Barometer, Total Wealth, Dynamic Wealth Report, Rick Saddler, Rockwell Trading, SmallCap Network, SmallCapVoice, Average Joe Options, Bourbon and Bayonets, TheStockAdvisors, The Stock Dork, Equities.com, The Night Owl, Inside Investing Daily, Stock Gumshoe, WStreet Market Commentary, Dividend Opportunities, Outsider Club, Power Profit Trades, The Best Newsletters, Investor News, InvestorsUnderground, FeedBlitz, The Trading Report, Trade of the Week, Daily Dividends, TradersPro, Prism MarketView, BUYINS.NET, OilAndEnergyInvestor, Wall St. Warrior, TheOptionSpecialist, Direction Alerts, InvestorsObserver Team, Tim Bohen, Stock Tips Network, Shah's Insights & Indictments, Lebed.biz, Contrarian Outlook, InvestmentHouse, 360wallstreet, Investor Ideas, 777 Stocks, Economic News Room, BillionDollarClub, InsiderTrades, bullseyeoptiontrading, Market Trends, Investors Underground, Market FN, Chaikin PowerFeed, Jason Bond, BullDogReporter, Penny Sleuth, The Wall Street Transcript, The Weekly Options Trader, Schaeffer’s, Options Trader Elite, Wall Street Window, TradeSmith Daily, Terry's Tips, Wealthpire Inc., Visual Capitalist, Trader Prep, Smart Investing Society, Stock Analyzer, SmallCapNetwork, Trading Markets and TradingMarkets reported earlier on Tesla Inc. (TSLA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

For years now, Tesla Inc. (NASDAQ: TSLA) has been synonymous with electric vehicle (EV) innovation and market dominance. However, this is about to change. The company’s dominance is being challenged in various countries across Europe and the United States even after a stellar performance last year.

A recent report from JATO Dynamics revealed how the American multinational automotive company is experiencing declining sales and market share amid growing competition. The data showed that in the first half of 2024, Tesla sales dropped by 8% and 13% in the U.S. and Europe, respectively.

Usually, a decrease in sales doesn’t mean a loss in market share, but in Tesla’s case, that is what it means. In Europe, the company’s sales volume dropped from 185,200 units to 161,300 units, signifying a decrease in market share from 19.8% to 17.2% in the battery electric vehicle (BEV) space. Likewise, Tesla saw its sales dip from 324,900 units to 299,200 units in the U.S., while its market share fell from 59.8% to 51.2%.

However, Tesla wasn’t the only car company that experienced declining sales in Europe in the first half of 2024; Volkswagen Group also suffered a significant loss. The German car manufacturer faced the highest decline in sales share, from 14.16 %  to 12.7%.

So, what is the reason for this decline? Experts believe several issues could be the cause. First, Tesla’s product lineup, while revolutionary in its time, is aging. Models such as the Model S introduced in 2010, the Model 3 in 2017 and the Model Y, now five years old, face stiff competition from upcoming and fresh models from rival automakers.

Secondly, Tesla’s strategy to aggressively lower EV prices is becoming old news. Even though the strategy introduced in 2023 boosted sales, it no longer works. Reports show it faces diminishing returns, considering that other car makers are also lowering theirs.

Newer entrants, particularly those in China such as XPeng Motors, BYD and NIO, that are producing cost-effective models, have made price competition more pronounced. In Europe, the competitive landscape has intensified significantly. Premium German brands and increased offerings from Chinese EV makers create tough competition. Similarly, established car makers such as Ford and Hyundai are ramping up their games here in the U.S. In the period when Tesla was experiencing a decline in sales, it experienced a substantial sales increase.

Tesla Inc. (TSLA), closed Wednesday's trading session at $215.99, off by 12.3346%, on 167,942,939 volume. The average volume for the last 3 months is 22,686 and the stock's 52-week low/high is $138.8025/$278.98.

DoubleDown Interactive (DDI)

InvestorBrandNetwork, QualityStocks, Zacks, MarketBeat and InvestorPlace reported earlier on DoubleDown Interactive (DDI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, will release its second quarter 2024 financial results on Aug. 12, 2024, after the market closes. In addition, the company plans to host a conference call and simultaneous webcast that same day at 5 p.m. ET. During the call, members of the DoubleDown management team will provide an overview of those Q2 2024  financial results, including a business update; time will also be allotted for a question-and-answer session. A replay of the webcast will be available on the company's website shortly after the event.

To view the webcast, visit https://ibn.fm/Op50B or https://ibn.fm/IRe9Z

To view the full press release, visit https://ibn.fm/guUU5

About DoubleDown Interactive Co. Ltd.

DoubleDown Interactive is a leading developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multiformat interactive entertainment experiences for casual players, bringing authentic Vegas entertainment to players around the world through an online social casino experience. DDI’s flagship social casino title, DoubleDown Casino, has been a fan-favorite game on leading social and mobile platforms for years, entertaining millions of players worldwide with a lineup of classic and modern games. Following its acquisition of SuprNation in October 2023, the company also operates three real-money iGaming sites in western Europe. For more information about this company, please visit www.DoubleDownInteractive.com.

DoubleDown Interactive (DDI), closed Wednesday's trading session at $11.985, off by 0.125%, on 12,080 volume. The average volume for the last 3 months is 1.31M and the stock's 52-week low/high is $6.95/$15.96.

FSD Pharma Inc. (HUGE)

QualityStocks, Schaeffer's, BioMedWire, PsychedelicNewsWire, BUYINS.NET, StockMarketWatch, StockEarnings, MarketClub Analysis, Broad Street, bullseyeoptiontrading, CFN Media Group, Fierce Analyst, AwesomeStocks, Penny Dreamers, Trading with Manny, StockWireNews and InvestorPlace reported earlier on FSD Pharma Inc. (HUGE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is reporting on the results of its annual general and special meeting of shareholders; the in-person meeting was held on July 22, 2024, in Toronto, Ontario. According to the report, shareholders were represented in person or by proxy at the meeting. Shareholders elected seven directors for the company, with the directors serving until the next annual meeting or until a successor is elected or appointed; the elected directors include Anthony Durkacz, Zeeshan Saeed, Dr. Lakshmi P. Kotra, Adnan Bashir, Dr. Sanjiv Chopra, Michael (Zappy) Zapolin and Dr. Eric Hoskins. In addition, shareholders reappointed MNP LLP as the company's auditor; approved a share consolidation resolution; approved a special resolution giving board members power to change the company’s name; passed a special resolution approving and ratifying the company's articles of amendment; and passed an ordinary resolution authorizing the board to approve the issue of additional Class A multiple voting shares.

To view the full press release, visit https://ibn.fm/BmMyn

About FSD Pharma Inc.

FSD is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), FSD is focused on the research and development of its lead compound, Lucid-MS (formerly Lucid-21-302) (“Lucid-MS”). Lucid-MS is a patented new chemical entity shown in preclinical models to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. FSD Pharma invented unbuzzd(TM) and spun out its OTC version to Celly Nutrition, a company led by industry veterans. FSD retains ownership of 25.71% of Celly Nutrition Corp. The agreement with Celly Nutrition also includes royalty payments of 7% of sales from unbuzzd until payments to FSD Pharma total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Additionally, FSD Pharma retains a large tax loss carry forward of approximately C$130 million and could be utilized in the future to offset tax payable obligations against future profits. FSD Pharma retains 100% of the rights to develop similar product or alternative formulations specifically for pharmaceutical/medical uses. FSD Pharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represent loans secured by residential or commercial property. For more information about the company, please visit www.FSDPharma.com.

FSD Pharma Inc. (HUGE), closed Wednesday's trading session at $0.1438, off by 5.5191%, on 735,499 volume. The average volume for the last 3 months is 2.097M and the stock's 52-week low/high is $0.13/$1.6799.

The QualityStocks Company Corner

Annovis Bio Inc. (NYSE: ANVS)

The QualityStocks Daily Newsletter would like to spotlight Annovis Bio Inc. (NYSE: ANVS).

Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer's ("AD") and Parkinson's disease ("PD"), today announced the receipt of U.S. Patent No. 12,042,482. The patent covers methods of treating acute traumatic brain injuries ("TBI") and preventing nerve cell death with its lead drug candidate, buntanetap. Buntanetap (formerly known as Posiphen or ANVS401) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein, and TDP43. This improves synaptic transmission, axonal transport, and reduces neuroinflammation. "We are thrilled to achieve this significant milestone for buntanetap," said Maria Maccecchini, Ph.D., Founder, President and CEO of Annovis. "Nerve cell death is a common underlying factor in many brain conditions, beyond just Alzheimer's and Parkinson's. Our preclinical studies in TBI and stroke animal models have demonstrated buntanetap's efficacy in preventing cell death and loss of function, and it is our duty to explore its potential benefits for victims of brain trauma, a prevalent issue in the U.S."

To view the full press release, visit https://ibn.fm/fWg1v

Annovis Bio Inc. (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD). Annovis Bio stands out by developing a drug that targets multiple neurotoxic proteins simultaneously, aiming to restore axonal and synaptic activity. This innovative approach aims to treat memory loss and dementia associated with AD and body and brain dysfunction associated with PD, making Annovis a unique player in the neurodegeneration space.

Lead Drug Candidate: Buntanetap

Buntanetap (formerly Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein, and TDP43. This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and protects nerve cells from dying. Unlike monoclonal antibody therapies, Buntanetap is an orally available small molecule capable of inhibiting multiple neurotoxic proteins at once, positioning it as a comprehensive solution for neurodegenerative diseases.

In a recent Phase II/III Alzheimer’s study, Buntanetap demonstrated statistically significant efficacy. Patients with early AD showed a significantly higher rate of improvement in ADAS-Cog 11 scores across all treatment doses compared to placebo, with a -3.3 point improvement compared to -0.3 for placebo (p < 0.01). Plasma Tau protein levels also reduced, consistent with previous Phase II biomarker data, further validating Buntanetap’s mechanism of action.

Similarly, in the Phase III study of Buntanetap in patients with early Parkinson’s disease, significant advancements were observed. Topline data results are anticipated in June 2024. Preliminary findings indicate promising results in improving cognitive and motor function, underscoring Buntanetap’s potential as a transformative therapy for Parkinson’s disease.

Market Opportunity

The aging population presents a significant market opportunity, with nearly 7 million Americans currently suffering from Alzheimer’s Disease (AD), a figure projected to rise to almost 13 million by 2050 (Alzheimer’s Association) (Republican Policy Committee). Additionally, approximately 1.2 million people in the U.S. have Parkinson’s Disease (SingleCare).

The economic burden of Alzheimer’s is immense, with care costs expected to reach $360 billion in 2024 and escalate to nearly $1 trillion annually by 2050. The need for effective, comprehensive treatments like Buntanetap is more critical than ever.

Company Highlights

  • Innovative Therapeutic Approach: Annovis Bio uniquely targets multiple neurotoxic proteins, aiming to restore nerve cell health and improve cognitive and motor function in AD and PD patients.
  • Robust Clinical Data: Phase II/III studies show significant improvements in cognitive function and biomarker levels in early AD patients.
  • Groundbreaking Clinical Insights: Preliminary results from Phase II studies indicate significant improvements in motor functions and speed in patients with Parkinson’s Disease (PD).
  • Upcoming Phase III Trials: Plans are underway for an 18-month Phase III trial focusing on biomarker-positive early AD patients, designed to further validate Buntanetap’s disease-modifying potential.
  • Capital Efficiency: Annovis Bio is capital-efficient, with zero debt and multiple global patents extending into the 2040s.

Management Team

Maria L. Maccecchini, Ph.D., Founder, President, CEO, and Executive Board Member, founded Annovis Bio in May 2008 with the mission to develop better therapeutics for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. She has previously been a partner and director at two angel groups, Robin Hood Ventures and MidAtlantic Angel Group, and founded Symphony Pharmaceuticals/Annovis, which was sold to Transgenomic in 2001. Her extensive experience includes roles such as General Manager at Bachem Bioscience and Head of Molecular Biology at Mallinckrodt. Dr. Maccecchini holds a Ph.D. in biochemistry from the Biocenter of Basel, with postdoctoral work at Caltech and the Roche Institute of Immunology.

Cheng Fang, Ph.D., Senior VP of Research and Development, is an accomplished neuroscientist with two decades of experience in neurodegenerative diseases. She has a successful track record of scientific publications and contributions, coupled with extensive pre-clinical and clinical development experience. Dr. Fang has been instrumental in advancing the understanding of neurodegenerative disease mechanisms and developing therapeutic strategies.

Michael Christie, Ph.D., VP of Process Chemistry, has over 40 years of experience in the pharmaceutical industry, focusing on process chemistry R&D, pilot plant production, and GMP operations. He has held senior management positions at companies such as SmithKline, Rhodia, Teva, and Cephalon, and founded a contract process R&D service company, which was later acquired by ChiRex. Dr. Christie is co-author or co-inventor on several publications and patents. He earned his BS in chemistry from the University of Michigan and his doctorate from MIT.

Melissa Gaines, Senior VP of Clinical Operations, is an accomplished clinical research professional with over 20 years of experience across academia, contract research organizations, and pharmaceutical companies. She has proven abilities in monitoring and managing Phase I to IV clinical trials, specializing in CNS disorders and extending to a broad range of therapeutic indications. Her CNS experience spans from small Phase I and II studies to large global Phase III trials in Alzheimer’s disease, Parkinson’s disease, sleep disorders, and various psychiatric diseases in both adult and pediatric populations. In her current role, she oversees and supports all clinical project activities, driving operational success and ensuring high-quality clinical outcomes.

Learn more about the Annovis Bio team on LinkedIn.

Annovis Bio Inc. (NYSE: ANVS), closed Wednesday's trading session at $10.77, up 1.1268%, on 696,461 volume. The average volume for the last 3 months is 112,657 and the stock's 52-week low/high is $4.53/$22.49.

Recent News

SenesTech Inc. (NASDAQ: SNES)

The QualityStocks Daily Newsletter would like to spotlight SenesTech Inc. (NASDAQ: SNES).

New York City has received lots of backlash, mainly from People for the Ethical Treatment of Animals ("PETA"), for its approach to addressing its rat problem

Its approach, so far, has been characterized by the use of traps, poisons, and its "Trash Revolution" program, all of which have been unsustainable

SenesTech, a rodent fertility control product provider, through its flagship Evolve(TM) product, offers an alternative that could potentially eliminate the entire rodent population in 12 to 18 months

This solution avoids the adverse effects of the use of poisons, both to humans and other animals, and offers a sustainable, more proactive alternative to tackling the problem

Following New York City's recent hard stance in the fight against rodents in the city, its leadership has been under backlash, mainly from People for the Ethical Treatment of Animals ("PETA"). The organization blamed the rat problem on the city's lack of proper systems and infrastructure to manage garbage, which ultimately attracts rats in the first place. But it has also raised concerns about the inhumane approach the city has taken to fight the rodent problem, such as poisons and traps, a move that has been termed as "villainizing rats for problems created by humans" (https://ibn.fm/lsmj1). New York has mainly dealt with the rat problem by poisoning them and controlling trash. Although the approach has helped, it is seen as inadequate, with real dangers for non-rodent populations, and, unsurprisingly, poisons (and traps when used) are viewed as inhumane for the rodents. SenesTech (NASDAQ: SNES), a rodent fertility control product provider and the inventor of the only EPA-registered contraceptive for male and female rats, offers what many are calling a clearly superior option, and one that could potentially eliminate the entire rodent population in 12 to 18 months (https://ibn.fm/i9oU9).

SenesTech Inc. (NASDAQ: SNES) is the rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats. The company’s technology provides an innovative and humane method for managing rat populations.

SenesTech is focused on developing effective solutions that are grounded in science and proven through research, all while providing value to people, communities and the environment. The company’s passion is to create a healthier world by better controlling rat pest populations. This aim is critical, as, if left unchecked, a breeding pair of rats and their descendants can produce up to 15,000 pups after just one year.

The company strives for clean cities, efficient businesses and happy households – with a product that was scientifically designed to be effective without killing rats. SenesTech is committed to the sustainable, humane treatment of animals, improving the quality of all human life and enhancing environmental stewardship through the global application of its effective solution in fertility control technology.

SenesTech is headquartered in Phoenix, Arizona.

ContraPest®

SenesTech’s first product, ContraPest®, applies revolutionary technology to a global challenge that has persisted since the Middle Ages – the proliferation of rats in urban and agricultural settings. ContraPest® targets the reproductive capabilities of Norway and roof rats. As a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down.

The company’s flagship offering can be used as part of integrated pest management (IPM) programs – fitting seamlessly into all IPM programs – to help reduce reproduction and magnify the success of these protocols, or as a standalone solution for customers who want to reduce or eliminate the use of lethal rodent control methods.

In multiple, independent field deployments, ContraPest was shown to reduce rat activity over 90% when added to an existing IPM program.

ContraPest® is registered federally as a General Use Product.

Delivery Systems and New Products

In July 2023, SenesTech began to distribute a new delivery system for ContraPest®, the Isolate Bait System™. This new delivery system brings to market a simple design that enables more efficient deployment, incorporates an enhanced formulation of ContraPest® that is expected to provide improved performance of the fertility control bait in the field and is paired with a new bait station that is more space-efficient and economical.

The other delivery systems available for ContraPest include the Ultimate Bait System™, a tank and tray in a larger format for use with more severe infestations, and the Elevate Bait System™, a unique delivery system that targets above ground infestations, as with roof rats.

SenesTech, as of August 2023, is also in the final stages of releasing a soft bait formulation, which provides the unique attributes of proven fertility control in an industry-familiar format demanded by big box retailers, key e-commerce channels and leading industry pest management professionals.

Market Opportunity

According to SenesTech’s figures, rats cause over $27 billion in damage to public and private infrastructure annually in the United States. Rats also destroy 20% of the global stored food supply every year by consuming or contaminating it.

Rats are known to spread at least 35 diseases, globally posing a dangerous risk to public health and safety. Not only does this age-old problem persist despite extensive campaigns to eradicate it, but multiple sources have reported that post-COVID rat populations have boomed.

Poison-based control methods sicken rats, and they typically die slowly. An animal that eats a poisoned rat may also sicken or die. The global rodenticide market is projected to be worth $1.7 billion by 2026.

In one case study, results reported by the customer showed a $5,000 investment in ContraPest® saved more than $500,000 annually in reduced labor, loss and damage.

Management Team

Joel Fruendt is SenesTech’s President and CEO. He has 15 years of executive leadership in the vector and pest control industries as Vice President and General Manager of Clarke Environmental Inc., a leading vector and pest control products and services company. He has extensive expertise in the development and manufacturing of EPA-registered chemical control products, and the commercialization and sale of those products. He received the ‘Smart Leaders’ award from Smart Business Magazine and holds a bachelor’s degree in business from Illinois Wesleyan University.

Tom Chesterman is CFO at SenesTech. He has over 20 years of experience as the CFO of public companies in the life science, tech and telecommunications industries. Most recently, he was the Vice President and Treasurer of GCI, a telecommunications company. Previous to that, he was the CFO of life science companies Bio-Rad Laboratories, Aradigm and Bionovo. He has a bachelor’s degree from Harvard University and an MBA from the University of California at Davis.

Dan Palasky is Chief Technical Officer at SenesTech. Previously he held the title of Vice President of Research & Development at PLZ Corp., a manufacturer of chemical consumer products, serving as the technical expert for its entire product portfolio. He started his career with Camie-Campbell, Inc., as a chemist in the R&D department. Mr. Palasky received his bachelor’s degree in chemical engineering from the Missouri University of Science & Technology and his MBA in Project Management from Aspen University.

SenesTech Inc. (NASDAQ: SNES), closed Wednesday's trading session at $0.4287, up 5.5651%, on 564,492 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $22.49/$.

Recent News

Correlate Energy Corp. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Energy Corp. (OTCQB: CIPI).

A recent poll has revealed that Latino voters in Arizona want their leaders to take more action on climate and clean energy. The Latino vote played a decisive role during the 2020 elections in Arizona and is likely to be equally decisive in the upcoming election. According to a survey by environmental justice outfit Chispa AZ, this group is likely to side with candidates who align themselves with clean energy and other climate-change mitigation efforts. After surveying 520 registered Latino voters in Arizona, the poll found that 70% of the respondents were concerned with climate change while 60% supported the state's increasingly stringent green-energy requirements for electricity-powered utilities. According to analysts, the Latino vote could be a game changer in a state such as Arizona where President Joe Biden beat former President Donald Trump in the last election, with a small margin of 11,000 votes to become the first Democratic candidate to win Arizona in more than two and a half decades. Georgia was the only state in the country to have an even narrower margin in the hotly contested 2020 presidential elections. Furthermore, the joint polling found that most Latino voters in the state were more drawn to the solutions offered by liberal candidates. The joint survey's results were in line with what environmental justice organization Chispa AZ found: Arizona's Latino voters are more likely to align themselves with Democratic candidates. This is especially likely after the current administration's leadership led to a surge in solar-energy jobs and in the face of climate change-caused issues such as asthma and heat, which are more likely to affect minority and low-income communities. For companies that focus on developing and selling green-energy solutions, such as Correlate Energy Corp. (OTCQB: CIPI), these revelations about voters scrutinizing candidates based on their views on climate action and clean energy show that the future of green-energy compaies is bright since the population is hankering for sustainable solutions.

Correlate Energy Corp. (OTCQB: CIPI) is a publicly-traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation.

The energy grid in the U.S. is insufficient for the booming clean energy trend, and current infrastructure is limiting green energy distribution. Constructing the needed infrastructure to address this demand imbalance will cost billions and be far too slow, positioning decentralized systems, like those on offer from Correlate, in a key position for heightened demand.

Correlate has identified several key economic drivers powering the decentralized energy trend, including:

  1. Real Cost Savings – Customer pays zero money down and gets an instant electrical price discount to current rates.
  2. Massive Project Investment Funding – The International Energy Agency estimates that over one billion dollars per day will be invested in solar energy in 2023.
  3. Consistent Long-Term Incentives – The Inflation Reduction Act is a game-changer, supercharging renewables with $1.2 trillion in tax credits for 10 years of market support.
  4. Robust Customer Demand – Wood Mackenzie expects the U.S. solar industry to nearly triple in size over the next five years.

Correlate’s team of multi-decade experts who have worked with renowned global brands are positioning the company to make the most of this opportunity while consolidating a fragmented industry. Collectively, the team has developed, financed and deployed over $2 billion in clean energy projects to date.

Three-Pronged Strategy

Correlate is leveraging a three-pronged strategy aimed at driving shareholder value:

  1. Sell – Correlate seeks to finance, develop and profitably sell localized clean energy solutions and microgrids to industrial, commercial and residential customers.
  2. Retain – Correlate plans to retain ownership of some of these energy systems and thereby realize ongoing, reliable cash flow.
  3. Acquire – Correlate seeks to acquire proven renewable energy companies in order to exponentially grow earnings per share for investors.

This strategy is enhanced by current investment trends. Clean energy earnings are being sought after by investors. In Q4 2022, the median EBITDA multiple for green energy companies was 12.3x, according to Finerva.

Market Outlook

Over the next decade and beyond, renewable energy growth is expected to come primarily via decentralized systems like those offered by Correlate.
The Inflation Reduction Act enacted in late August 2022 is likewise expected to drive growth for the company by providing new tax incentives that reduce costs for clients and/or elevate returns to investors.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings, yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which are very different from traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue, known as the ‘split incentive’, unlocking the majority of the addressable market.

A key portion of Correlate’s strategy relates to consolidation of what has been a fragmented industry. By uncovering opportunities to improve efficiencies through strategic M&A activities, the company intends to enhance profitability throughout its operations.

Management Team

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

Dave Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jed Freedlander is the company’s Chief Development Officer. He has a background in infrastructure development and investment and a strong legal, commercial and finance acumen. Mr. Freedlander has a proven track record in leading complex public-private partnership (P3) and energy transactions and is instrumental in driving Correlate’s strategic development initiatives.

Roger Baum is Executive VP Operations at Correlate. With over 20 years of experience at Core Construction, he brings to the company a wealth of knowledge and a strong track record in delivering successful commercial construction projects.

Jason Loyet is Director of Solar Energy for Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Correlate Energy Corp. (OTCQB: CIPI), closed Wednesday's trading session at $0.439, up 82.9167%, on 1,036 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.05/$2.35.

Recent News

Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF)

The QualityStocks Daily Newsletter would like to spotlight Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF).

Trillion Energy (CSE: TCF) (OTCQB: TRLEF), a company focused on oil and natural gas production for Europe and Türkiye with natural gas assets in Türkiye, today provided an update on the flow rates and well perforations at the SASB gas field. According to the update, the well head pressure ("WHP") at South Akcakoca-2 has stabilized at 371 psi, with the well recently producing 1.94 MMcf/d using 42/64" choke, while Guluc-2 is currently producing at 3.35 MMcf/d with a WHP of 484 psi using a 32/64" choke. At West Akcakoca-1, where only two of the five zones have been perforated, the WHP went from 1150 psi to 1350 psi. Akcakoca-3 was perforated over 11 meters of gas pay with no observable WHP increase, most likely due to water loading, according to the company; it is expected to come back on at about 2 MMcf/d upon installation of a velocity string (2 3/8 production tubing).

To view the full press release, visit https://ibn.fm/WYc18

Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF), along with its consolidated subsidiaries, is a Canadian oil and gas exploration and production company with operations primarily focused in the Republic of Türkiye.

Headquartered in Canada, the company owns 49% of the SASB natural gas field, which is producing critical domestic supply of natural gas during Europe’s ongoing energy shortages. It also holds a 19.6% (except three wells with 9.8%) ownership interest in the Cendere Oil Field and has a farm-in agreement to earn 50% interest in three oil exploration blocks in southeast Türkiye called Cudi-Gabar.

Trillion Energy utilizes state-of-the-art technology and ingenious practices to produce and distribute oil and natural gas while still maintaining a commitment to sustainable and responsible operations. Whether through the development of new projects or optimizing existing assets, the company continues to seek new and innovative ways to drive growth and value for its stakeholders.

Headquartered in Vancouver, British Columbia, Trillion Energy is led by seasoned professionals who collectively boast over a century of energy exploration and development experience.

Projects

SASB Gas Field

The SASB Gas Field is producing and delivering critical domestic supplies of natural gas as energy shortages grip Europe due to Russia’s invasion of Ukraine.

Located in the southwestern Black Sea, the SASB gas field consists of numerous conventional natural gas pools located in shallow water. The fields have produced over 43 billion cubic feet (BCF) since initial development in 2007 and continue to provide much needed energy to Türkiye and the EU. Total infrastructure to date, including production platforms, pipelines, initial wells and gas processing plant, cost in excess of $600 million.

Trillion Energy is redeveloping the field with a strategic planned program of approximately 17 wells which commenced in 2022. Phase B of the program, targeted for 2024/25, consists of the re-entry of five legacy wells to drill sidetrack development wells and one exploration stratigraphic well.

Cendere Oil Field

Trillion Energy’s Cendere oil field is a long-term, low decline, stable oil production field located in Türkiye. The company has a 19.6% interest in the field, except for three wells in which its interest is 9.8%.

Cash flow after operating costs from the field is $120,000 to $140,000 per month, with average current production netting the company 110-120 barrels of oil per day. Estimated remaining Cendere oil reserves total 1.5 million barrels (0.277 million barrels net Trillion Energy).

The gross value of Trillion Energy’s interest is estimated at $13.85 million (NPV10).

Cudi-Gabar

Trillion Energy’s 10-well oil exploration drilling program is occurring on three prospective oil blocks located in the prolific Cudi-Gabar oil province in southeast Türkiye. The total area of the three blocks is 374,325 acres.

Trillion Energy’s potential 50% working and revenue interest in the blocks is earned by paying 100% of the work program costs. The company will operate the exploration program.
During 2023/24, Trillion Energy will shoot 351 kilometers of 2D seismic (150 km already shot on the eastern block) and drill four wells. The remaining six wells will be paid 50% by Trillion and 50% by the company’s partner. The oil blocks are surrounded by more than 10 major oil discoveries, half of which are recent.

Market Opportunity

A January 2024 report by Emergen Research, a market research and consulting company, estimated the global natural gas market at $310.5 trillion in 2022 and projected the market will be worth $443.8 trillion by 2032, achieving a CAGR of 3.7% during the forecast period. Increasing global economic activity and rising electricity consumption are key factors driving revenue growth of the market, according to the report.

Trillion Energy reports strong demand for natural gas in Türkiye, which is the seventh-largest natural gas consuming country in the world. Türkiye currently imports 98% of the natural gas it consumes, with about 60% of those imports coming from Iran and Russia.

Management Team

Dr. Arthur Halleran is CEO and Director of Trillion Energy. He has a Ph.D. in Geology from the University of Calgary and 44 years of petroleum exploration and development experience. His international experience includes work in Canada, Colombia, Egypt, India, Guinea, Sierra Leone, Sudan, Suriname, Chile, Brazil, Bulgaria, Türkiye, Pakistan, Peru, Tunisia, Trinidad Tobago, Argentina, Ecuador and Guyana. Dr. Halleran has worked for Petro-Canada, Chevron, Rally Energy and United Hydrocarbon International Corp. In 2007, he founded Canacol Energy Ltd., now the largest natural gas producer in Colombia.

Al Thorsen is COO of Trillion Energy. He is responsible for production operations of the SASB gas field, as well as future drilling activities in Türkiye and abroad. Highlights of his career include Valeura Energy Inc. as operations manager in Türkiye; Journey Energy, leading a production team; Rio Alto Exploration as country manager and production manager; Zargon Oil and Gas as VP of Operations; Orleans Energy as VP of Operations; and Central Petroleum as COO. He holds a Bachelor of Science in Petroleum Engineering from Montana College of Mineral Science & Technology.

Trillion Energy International Inc. (OTCQB: TRLEF), closed Wednesday's trading session at $0.1172, up 7.5723%, on 450,350 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0682/$1.383.

Recent News

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF)

The QualityStocks Daily Newsletter would like to spotlightFathom Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF).

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF), a publicly traded mineral exploration company exploring for high-grade copper and gold deposits in Virginia and Nunavut, Canada, along with its joint venture partner American West Metals Limited, is reporting on the status of drilling and exploration activities currently underway at the Storm Copper Project. The project is located on Somerset Island, Nunavut, and is being conducted by American West Metals Limited, which has formed a 20/80 unincorporated joint venture with Aston Bay on the project. Highlights of the update indicate that the excellent productivity for the 2024 summer drilling program is continuing with more than 8,300 meters being completed in 66 reverse circulation ("RC") and diamond drill holes. The company has received visual results from an additional 22 drill holes and expects the first assays for the summer program within the next two weeks. "The impressive visual results continue to come in from the drilling at Storm, highlighting the significant potential for growth and delineation of a potential future resource at the project as well as additional discoveries," said Aston Bay CEO Thomas Ullrich in the press release. "Equally impressive are the efforts of the entire crew of drillers, geologists, geophysicists, pilots and camp support staff — we thank them for delivering results and credit them all for the success of the ongoing program."

To view the full press release, visit https://ibn.fm/0531U

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) is a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America. The company owns the Storm Copper Project and the Seal Zinc Deposit in Nunavut, Canada, and is currently exploring the Buckingham Gold Vein and critical metals prospects in central Virginia. Aston Bay is also in the advanced stages of negotiation on other properties with high-grade critical minerals potential in these areas.

The company believes in responsible exploration and carries out its work programs to the highest standards of social responsibility, environmental stewardship and health and safety. Aston Bay cares about leaving a net positive impact on the communities in which it works and engages with local representatives, Indigenous groups and government agencies to build respectful relationships through dialogue and collaborative processes. Depending on the stage of exploration, these efforts may include employment, contracting, training, community benefits and other agreements.

Aston Bay conducts exploration through safe, socially and environmentally responsible and sustainable work practices. The company embeds core values of health and safety throughout its operations by adhering to strict health and safety standards and practices that meet and/or exceed industry standards and government codes and regulations.

The company is headquartered in Toronto.

Projects

Storm Copper

The high-grade Storm Copper Deposit is located 112 kilometers south of the community of Resolute Bay, Nunavut, on western Somerset Island, just south of the past-producing Polaris Pb-Zn Mine. The property comprises 173 contiguous mining claims, including the Storm Copper and Seal Zinc projects, covering an area of approximately 541,795 acres.

The property has good access to established shipping lanes, and the landscape provides favorable conditions for development of roads and a protected deep-water port. Exploration is supported through excellent infrastructure in the nearby hamlet of Resolute Bay.

Aston Bay is partnered with American West Metals (ASX: AW1) at Storm. American West is responsible for all exploration expenditures, having aggressively advanced the project toward production and earned an 80% interest. This affords excellent optionality to the company’s shareholders, as Aston Bay is free carried with no required expenditures until the completion of a bankable feasibility study.

American West recently completed an Australian JORC-compliant Maiden Resource Estimate for Storm; the North American 43-101 compliant resource estimate is expected in Q1 2024. American West is cashed up and plans a multimillion-dollar resource expansion and new discovery drilling program for the summer of 2024.

The Buckingham County Gold Project

The gold-bearing system at the Buckingham County Gold Project in Virginia lies within a belt hosting past producing mines, current gold mines and advanced gold explorations, stretching through Georgia, the Carolinas, Virginia, Nova Scotia and Newfoundland.

Buckingham hosts a “Kirkland Lake-style” high grade gold vein returning values consistently over one ounce gold per ton and is underexplored both at depth and along almost one mile of strike length. These types of veins have excellent ESG qualities, as they are typically mined using a small footprint underground method, with gold extracted using simple and environmentally friendly gravity methods.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

A report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Thomas Ullrich is CEO and Director of Aston Bay. He has over 30 years of experience in mineral exploration and geoscience. Before joining Aston Bay, he was Chief Geologist North America for Antofagasta Minerals plc, investigating copper potential through extensive property evaluations and management of drill programs in the United States, Mexico and Canada. Prior to that, he was Senior Geologist for Almaden Minerals.

Sofia Harquail handles Investor Relations and Corporate Development at Aston Bay. She has over 15 years of experience in the private and public sectors of the mining industry. Before joining Aston Bay, she worked as a consultant for the Prospectors and Developers Association of Canada and for exempt market dealer Red Cloud Financial Services Inc. Ms. Harquail holds an M.A. from the University of Uppsala in Sweden and received her CPIR designation from the CIRI/Ivey Investor Relations Program. She also sits on the board of the Young Mining Professionals Toronto and is CSC Certified.

Aston Bay has a talented Board of Directors bringing broad experience from across the industry, encompassing resource expansion, mine development, mergers and acquisitions, and mining finance.

Ms. Jessie Liu-Ernsting has over 15 years of experience in the mining industry, spanning capital projects engineering, debt capital markets, private equity and corporate strategy at several firms, including Hudbay Minerals and Resource Capital Funds. She is currently VP Investor Relations and Communications at G Mining Ventures Corp.

Mr. Jeffrey R. Wilson has over 25 years’ experience in the mining industry, having served as a director, officer and advisor of multiple public and private companies in the mineral exploration and mining investment industries. Mr. Wilson is currently President & CEO of Precipitate Gold Corp.

Mr. Gary O’Connor has over 40 years of diverse experience as a mineral exploration and development professional in the management of successful resource projects as well as the evaluation, technical due diligence, and supervision of large mineral exploration and development projects through-out the world. While with Freeport, Mr. O’Connor worked on the due diligence and discovery of a major gold fraud on the Busang gold “deposit” in Kalimantan by Bre-X.

Mr. Mark J. Pryor is a geologist with a 40-year track record of successfully advancing multiple precious metal, copper, coal, REE and Li projects from discovery through to exploitation. He is currently Executive Vice President of the Exploration Division at The Electrum Group.

Aston Bay Holdings Ltd. (OTCQB: ATBHF), closed Wednesday's trading session at $0.0804, up 0.5%, on 42,500 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0268/$0.2474.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

A number of European marijuana start-ups are thinking about listing in New York due to the anticipated reclassification of marijuana by federal authorities as a less harmful narcotic. Although the companies haven't finalized their plans, they are drawn to the U.S. market's increasingly favorable stance on cannabis and CBD products. Statista estimates that this year's CBD market might be valued at approximately $6.90 billion. Under the new U.S. regulations, cannabis may be moved from the highly restrictive Schedule 1 of the Controlled Substances Act (CSA), which also includes LSD, heroin, and fentanyl, to the less restrictive Schedule 3, placing it in the same category as ketamine and anabolic steroids. However, critics counter that marijuana might be toxic and could serve as a gateway drug for more potent substances. As marijuana companies in Europe prepare to list in the United States, they will find other established companies such as Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) already accessing capital from North American investors, and competition for these resources could tighten even more.

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.

Production

MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Wednesday's trading session at $0.028, even for the day, on 18 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.000001/$0.09.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an electric vehicle ("EV") manufacturer, has received an order for 29 Mullen GOS from one of its newest European distribution partners. The order for the GOs, which are Mullen's commercial micro-urban-delivery vehicle, came from GAMA, which is a distribution partner covering southeast Europe, including the Balkans Region. The order from GAMA, which is valued at $304,000, is part of a previously announced 53-unit commercial vehicle order; that order is for urban delivery vehicles as well as Mullen One and Mullen Three commercial EV cargo vans and trucks, which have not yet been delivered. The compact design of the Mullen-GO makes it an ideal vehicle "bridge the gap between the growing demand for quick deliveries and space constraints in dense cities throughout Europe," the company noted. "GAMA is seeing strong interest in our commercial EVs, and we are delighted to begin vehicle deliveries in the Balkans region," said Mullen Automotive CEO and chair David Michery in the press release. "As highlighted previously, the Mullen GO is the perfect micro urban delivery vehicle for small and congested old world European streets."

To view the full press release, visit https://ibn.fm/mb4Af

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Wednesday's trading session at $1.23, off by 10.219%, on 4,715,998 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.21/$155.70.

Recent News

NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW)

The QualityStocks Daily Newsletter would like to spotlight NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW).

July 16, 2024, marked the beginning of this year's Amazon Prime Day, which established a new record in online shopping. The annual two-day sale, which ended on July 17, saw consumers in America spend more than $14 billion. This year's figure represents an 11% rise in consumer spending, as 2023's total consumer spending stood at $12.7 billion. On the first day of the sale, $7.2 billion was spent by consumers. During the same period in 2023, consumers spent 11.2% less. The momentum grew on day two of the sale, with consumer spending hitting $7 billion. Prime Day has a significant impact on the global e-commerce market, driving sales for retailers that promote their products during this sale period and bringing in additional revenue for Amazon. This huge success registered by Amazon should push other players such as NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) to aim for even greater success as they deploy cutting-edge technologies in their bid to expand their reach both among sellers and buyers.

NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW), a next generation e-commerce platform, was created with vision and purpose to capitalize on high growth sectors and global markets. The company collaborates with businesses – large and small – to simplify and accelerate online commerce and uniquely enables customers and partners to optimize their e-commerce reach, presence and revenue. NextPlat recently launched a new e-commerce development program to provide American businesses with easy access to the massive Chinese consumer market.

Current Initiatives

NextPlat provides cutting edge technology in an advanced e-commerce ecosystem. The company is actively expanding its global network of online storefronts serving thousands of consumers, enterprises and governments. The company also has developed a next generation platform built for Web3 that enables the creation and sale of digital assets, as well as optimizing e-commerce transactions and business building activities. The company’s current initiatives include:

  • E-Commerce Development Program – In April 2023, NextPlat announced it had entered into a merchant sourcing agreement with Alibaba.com Singapore E-Commerce Private Limited (“Alibaba”) and its Tmall Global e-commerce platform whereby the two companies will collaborate to increase the sale of products produced and sold by American companies to the multi-trillion-dollar Chinese consumer market. Alibaba’s Tmall Global e-commerce platform will provide NextPlat customers a turn-key solution through which products can be sold to the Chinese consumer market. The launch of the Florida E-Commerce Development Program is the first in a series of new NextPlat programs designed to assist U.S. businesses in expanding their online sales capabilities to reach new international customers in the Chinese market. NextPlat intends to rapidly expand this unique e-commerce development opportunity to businesses throughout the United States and all of North America, as well as Central and South America. The new development program features NextPlat’s turnkey global e-commerce solution for customers and leverages NextPlat’s relationships with key partners, including Tmall Global, China’s largest cross-border B2C online marketplace.
  • Progressive Care Inc. – In August 2022, NextPlat completed a strategic $7 million investment in Progressive Care Inc. (OTCQB: RXMD), a personalized health care services and technology company. In a news release announcing the investment, NextPlat CEO Charles M. Fernandez noted that the company is “committed to harnessing the power of digital technologies to capitalize on the ongoing digital transformation of Progressive Care and the entire health care industry.” NextPlat intends to accelerate Progressive Care’s digital health care transformation with the launch of a new e-commerce platform for health care products later this year.
  • NextPlat NFT Platform – Building on its existing e-commerce initiatives, NextPlat is working to bridge the gap between tangible and digital e-commerce marketplaces by incorporating burgeoning Web3 technologies. The company intends to launch a fully integrated NFT platform in the coming months that will enable brands to create, manage and authenticate digital assets while serving as a new source of revenue for NextPlat. Through this model, the company will receive a portion of the revenue generated from branded NFT drops, as well as subsequent secondary market transactions.
  • Global Telesat Communications and Orbital SatCom Corp. – Targeting both domestic and international markets, NextPlat’s subsidiaries leverage partnerships with major e-commerce platforms such as Amazon, Alibaba, eBay and Walmart to serve a growing base that includes more than 50,000 corporate, governmental and individual customers. In total, the brands market more than 10,000 individual products, with a focus on satellite-based connectivity solutions. In addition to exploring accretive M&A opportunities, NextPlat aims to diversify its range of products and broaden its geographic footprint moving forward in an effort to better capitalize on the tremendous growth potential in the United States, Europe and Asia.

“Our goal for 2023 and beyond is to leverage our improved operational capabilities and enhanced leadership team as we expand our offerings in communications and connectivity into the high-growth health care market where we intend to launch an array of innovative new offerings,” Fernandez said in a March 2023 news release detailing the company’s record top-line performance. “Although there remain supply chain headwinds and the challenge of global inflation, we are confident that we have the right combination of market-tested expertise, technology and partnerships that will enable us to bring the power of e-commerce to more customers, brands and industries in the United States and abroad.”

Market Opportunity

The rapid growth of e-commerce over the last decade is expected to continue for the foreseeable future. According to data published by Forbes, roughly 20.8% of all retail purchases are expected to take place online in 2023, accounting for total sales of $6.31 trillion worldwide. It total, e-commerce sales are expected to grow by 10.4% YoY in 2023, accounting for a whopping 24% of all retail purchases by 2026.

For NextPlat, existing partnerships in the industry could be key to capitalizing on this growth. The Forbes report indicates that Amazon accounts for roughly 38.7% of e-commerce sales, while sites like Walmart, eBay and Alibaba round out the list of most visited e-commerce websites. Alibaba is especially interesting due to NextPlat’s recent strategic merchant sourcing agreement with Tmall Global. The Chinese market is “mammoth,” as a recent Alizila report noted. The country’s annual online retail sales of physical goods have nearly doubled in the last five years, reaching approximately 13.8 trillion yuan in 2022, which is nearly $2 trillion USD.

The health care portion of the e-commerce market is generating particularly bullish forecasts, bolstered by the continued adoption of the 340B Drug Pricing Program in the U.S., which requires most drug manufacturers to provide outpatient drugs to covered entities at significantly reduced prices. Industry reports suggest that the global health care e-commerce market will expand at a compound annual growth rate of 16.8% from 2022 to 2030, climbing to a value of more than $1.37 trillion by the end of the forecast period.

Management Team

Charles M. Fernandez, CEO, Executive Chairman and Director of NextPlat, has over three decades of experience in identifying profitable start-up and dislocation opportunities, building significant value and executing exit strategies as an entrepreneur and global investor. Successful across multiple sectors, Fortune Magazine actually labeled Fernandez ‘a restructuring whiz’. As President of Fairholme Capital Management, which he joined in 2008, Mr. Fernandez co-managed all three Fairholme funds and brought in a $2 billion gain for shareholders. Throughout his impressive career, he has participated in more than 100 significant mergers, acquisitions and product development projects across multiple industries. Mr. Fernandez was the founder, Chairman and CEO of eApeiron Solutions LLC, a brand protection and e-commerce company in partnership with Alibaba (NYSE: BABA) and Eastman Kodak (NYSE: KODK), which was successfully sold to Smartrac, a unit of Avery Dennison Corp. (NYSE: AVY).

Rodney Barreto is Chairman and CEO of the Barreto Group and Director of Nextplat. Mr. Barreto’s business career spans over 35 years, including his role at the Barreto Group and, earlier, as the founding partner of Floridian Partners LLC, a corporate and public affairs consulting firm recognized by policy makers as one of the top in its industry in Florida. He chaired the Super Bowl Host Committee in 2007, 2010 and 2020, helping to raise more than $100 million for the success of Miami Super Bowls. As a philanthropist and conservationist, Mr. Barreto is also a three-time appointee to the Florida Fish and Wildlife Conservation Commission, where he has served for over 10 years including holding the title of Chairman eight times. He has twice chaired the Annual U.S. Conference of Mayors, was Chairman of the 1999 Breeder’s Cup Championship held in South Florida and was the Chairman of the 1999 Sister Cities International Convention in Miami. Currently, Mr. Barreto is the Membership Chairman of the Florida Council of 100, and a member of the Boards of Fairchild Tropical Botanic Garden, the Baptist Health South Florida Giving Society, the Bonefish and Tarpon Trust, the Guy Harvey Ocean Foundation, and a member of Miami Dade County Schools Superintendent Carvalho’s Business Advisory Council. Prior to his career in public affairs and real estate, Mr. Barreto was a City of Miami police officer and is a member of the Florida Highway Patrol Advisory Council.

NextPlat Corp. (NXPL), closed Wednesday's trading session at $1.185, off by 2.0175%, on 30,119 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.00/$3.08.

Recent News

InMed Pharmaceuticals Inc. (NASDAQ: INM)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals Inc. (NASDAQ: INM).

Age-related macular degeneration is a disease significantly impacting the quality of life, making it difficult for individuals to perform everyday activities such as reading, driving, and recognizing faces

InMed is currently developing a pipeline of drugs, like INM-089, to treat diseases with a high unmet medical need

Delivers improved retinal pigment epithelium integrity, neuroprotection and photoreceptor improvement in in vivo preclinical disease model

Age-related macular degeneration ("AMD") is a prevalent eye condition that primarily affects older adults, leading to vision loss in the central part of the retina, known as the macula. This disease significantly impacts the quality of life, making it difficult for individuals to perform everyday activities such as reading, driving, and recognizing faces. InMed Pharmaceuticals (NASDAQ: INM), a clinical stage company developing a pipeline of pharmaceutical drug candidates to treat several diseases with a high unmet medical need, is at the forefront of developing innovative treatments for this debilitating condition, with their flagship product INM-089 showing great promise.

InMed Pharmaceuticals Inc. (NASDAQ: INM) is a global leader in the manufacturing and clinical development of rare cannabinoids. InMed is a clinical stage company developing cannabinoid-based pharmaceutical drug candidates, as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids.

The company is dedicated to delivering new therapeutic alternatives to treat conditions with high unmet medical needs. The company is also developing a proprietary manufacturing technology to produce pharmaceutical-grade rare cannabinoids in the lab and has recently announced an LOI to acquire a leading rare cannabinoid manufacturer.

Research and Technology

There are more than 100 rare cannabinoids found in only trace amounts in the cannabis plant, together making up less than 1% of the plant’s biomass. InMed is initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need. Preclinical studies of CBN demonstrated an excellent safety profile and showed CBN has potential for therapeutic benefit over other cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD).

Evidence suggests there may be great therapeutic potential in rare cannabinoids. Each has a specific chemical structure, and different cannabinoids have been observed to have distinct physiological properties in humans, including therapeutic potential for specific diseases as well as unique safety profiles. CBN is the active pharmaceutical ingredient (API) in InMed’s two lead programs for dermatological and ocular diseases.

InMed’s most advanced compound, INM-755, is a CBN topical cream under clinical development for the treatment of epidermolysis bullosa, a severe genetic skin disorder. To date, INM-755 has been evaluated in two Phase 1 clinical trials in healthy volunteers. InMed has filed Clinical Trial Applications in several countries as part of a global Phase 2 clinical trial of INM-755 (cannabinol) cream in epidermolysis bullosa. Responses from the National Competent Authorities and Ethics Committees are expected throughout the summer of 2021.

InMed is also involved in developing INM-088, an ocular CBN formulation being researched for the treatment of glaucoma, the second leading cause of blindness in the developed world. InMed is currently evaluating several formulations to deliver CBN into the eye to address issues of dosing frequency, side effects and treatment penetration. INM-088 is being designed for topical delivery to the eye. This localized delivery results in very little drug being absorbed or migrating into the bloodstream, thus minimizing potential adverse side effects. INM-088 shows promise to reduce intraocular pressure and provide neuroprotection of the eye.

Manufacturing

The limited availability of rare cannabinoids like CBN makes them economically impractical to extract directly from the plant for pharmaceutical use. InMed is developing IntegraSyn, a cannabinoid synthesis manufacturing system to create rare cannabinoids in the lab that are bioidentical to the compounds derived from the cannabis plant. IntegraSyn uses multiple standard pharmaceutical processes and has achieved a cannabinoid yield of 5 grams per liter, surpassing commercial viability and significantly exceeding currently reported industry yields. InMed is now focusing on manufacturing scale-up to larger batch sizes while continuing process optimization, targeting increased cannabinoid yield and further reducing overall cost of goods.

BayMedica Inc. Acquisition

On June 29, 2021, InMed announced it had entered into a non-binding letter of intent to acquire BayMedica Inc., a private company based in Nevada and California that specializes in the manufacture and commercialization of rare cannabinoids.

As noted in the news release, BayMedica is a revenue-stage biotechnology company leveraging its significant expertise in synthetic biology and pharmaceutical chemistry to develop efficient, scalable and proprietary manufacturing approaches to produce high quality, regulatory-compliant rare cannabinoids for consumer applications. BayMedica is currently commercializing the rare cannabinoid CBC (cannabichromene) as a B2B supplier to distributors and manufacturers marketing products in the health and wellness sector. BayMedica is planning additional rare cannabinoid launches for the coming year.

Pursuant to the indicative terms of the LOI, InMed and BayMedica intend to negotiate and enter into a definitive agreement under which InMed would acquire 100% of BayMedica in exchange for 1.6 million InMed common shares to be issued to BayMedica’s equity and convertible debt holders, with any such issued InMed common shares being subject to a six-month contractual hold period.

Market Outlook

There is a rapidly growing demand for rare cannabinoids. However, their low natural concentration makes traditional harvesting of these compounds cost prohibitive. Biosynthesis allows production of rare cannabinoids in the lab that are bioidentical to compounds found in nature, with significantly higher yields which reduce costs. Biosynthesis can produce pharmaceutical-grade, bioidentical, THC-free compounds at a cost that’s 70 to 90 percent less than wholesale prices of naturally harvested rare cannabinoids.

Cannabinoid-based pharmaceuticals are expected to overtake the market as rare cannabinoids become less expensive and more available. According to Statista, the value of the consumer market for cannabinoid-based pharmaceuticals in the United States is forecast to grow to $25 billion by 2025 and to $50 billion by 2029, with cannabinoid-based pharmaceuticals used to treat health conditions including pain, respiratory conditions, autoimmune conditions and more.

Management Team

Eric A. Adams has been CEO and president of InMed since June 2016. He has more than 25 years of experience in establishing corporate entities, capital formation, global market development, mergers and acquisitions, licensing and corporate governance. He previously served as CEO at enGene Inc. Prior to enGene, he held senior positions in global market development with QLT Inc. (Vancouver), Advanced Tissue Sciences Inc. (La Jolla, CA), Abbott Laboratories (Chicago, IL) and Fresenius AG (Germany).

Bruce S. Colwill is InMed’s CFO. He has more than 25 years of financial leadership experience in public and private companies. Prior to InMed, he served as CFO of General Fusion Inc., a private clean energy company. He was also CFO at Entrée Resources Inc., a mineral exploration company, from 2011 to 2016. He has held CFO roles at Neuromed Pharmaceuticals Ltd., Response Biomedical Corp, Forbes Medi-Tech Inc. and Euronet Worldwide Inc.

Alexandra D.J. Mancini is Senior Vice President, Clinical and Regulatory Affairs at InMed. She has more than 30 years of global biopharmaceutical research and development experience. She has been an executive with numerous biotech companies, including senior vice president of Clinical and Regulatory Affairs at Sirius Genomics; senior vice president of Clinical and Regulatory Affairs at INEX Pharmaceuticals; and vice president of Regulatory Affairs at QLT Inc.

Eric C. Hsu is Senior Vice President, Pre-Clinical Research and Development at InMed. He joined InMed with more than 18 years of scientific leadership experience in the field of gene therapy. He has held various positions within enGene Inc., including vice president of Research and vice president of Scientific Affairs and Operations. He received his Doctorate from the Department of Medical Biophysics at the University of Toronto.

Michael Woudenberg is Vice President, Chemistry, Manufacturing and Controls at InMed. He has more than 20 years of successful drug development, process engineering, GMP manufacturing and leadership experience. He has held positions with 3M, Cardiome Pharma, Arbutus Biopharma and, most recently, was Managing Director of Phyton Biotech LLC.

InMed Pharmaceuticals Inc. (INM), closed Wednesday's trading session at $0.254, off by 1.5504%, on 4,184,652 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2122/$2.08.

Recent News

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF)

The QualityStocks Daily Newsletter would like to spotlight First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) .

Over the last few years, we have seen environmental, social, and governance (ESG) reporting frameworks grow in importance. This comes as more investors hold the opinion that companies  which perform well on ESG are better positioned for the long-term. In the past, greenwashing was a huge issue, with inaccurate data being published for the public. Now with transparency increasing, other challenges have come up. Below, we look at some of the challenges that fintech companies are now facing with regard to ESG. Environmental impact is often at the forefront during discussions on ESG. While this is good, it is important for fintech companies to ensure that they focus on social and governance as well. For companies that are primarily focused on mineral extraction, such as First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF), ESG challenges are mostly different from those faced by fintech. The challenges these companies face include how to minimize damage to the surface of the land where they have mining operations.

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) is committed to exploring for and providing essential and critical metals, including tellurium, gold, silver, copper and tungsten, for North American markets. This objective is anchored by the company’s Deer Horn tellurium-gold-silver-copper project in British Columbia, Canada, and further enhanced by its property option on the Klondike tellurium-gold prospect located in Colorado, USA.

First Tellurium’s unique business model is to generate revenue and value through mineral discovery, project development, project generation and cooperative access to untapped mineral regions in indigenous territory with sustainable exploration potential.

The company is headquartered in Vancouver, British Columbia.

Tellurium and the Green Energy Revolution

Tellurium has a key role to play in the ongoing green energy revolution. It is widely used in the manufacturing of photovoltaic cells for solar panels.

Despite this utility, ongoing trade tensions between China and the U.S. create implications for both tellurium and the production of cadmium-tellurium solar cells. Earlier this year, China announced plans to restrict exports of critical metals gallium and germanium, both essential for the production of semiconductors. For reference, China produces around 80% of the world’s gallium and approximately 60% of the world’s germanium.

China’s recent trade restrictions amplify the fragility of the North American tellurium supply, as the Asian nation currently produces about 60% of the world’s tellurium. This sustained supply vulnerability is why First Solar, the United States’ largest solar panel producer, set up a worldwide search for tellurium deposits in the mid-2000s.

“In North America alone, our understanding is that First Solar looked at over a hundred tellurium properties,” First Tellurium CEO Tyrone Docherty stated in a news release. “Their number one property by far, which they acquired, was the Colorado Klondike which we now control.”

The U.S. is now looking to secure safe, domestic sources of tellurium and many other critical metals to pre-empt potential shortages. The Biden administration has instituted a stream of policies, particularly the U.S. Inflation Reduction Act, to source solar components from North America and other “friendly” jurisdictions.

As the only junior mining company in the world focused on tellurium exploration, First Tellurium is ahead of the curve in capitalizing on these initiatives to establish strategic, domestic supplies of key resources for solar panel manufacturers.

First Tellurium’s ESG Initiatives

Through its exploration and partnerships with Fenix Advanced Materials, Cheona Metals and IRMA, First Tellurium strives to generate a measurable, beneficial social or environmental impact alongside a financial return. The company conducts a diversified search for metals, working in alliance with indigenous peoples, NGOs, governments and leading metals buyers. First Tellurium believes this is the future of mineral exploration — generating revenue by exploring responsibly and leveraging diverse partnerships.

First Tellurium proudly adheres to, and supports, the principles and rights set out in the United Nations Declaration on the Rights of Indigenous Peoples and, in particular, the fundamental proposition of free, prior and informed consent.

 

Projects

Deer Horn Tellurium-Gold-Silver-Copper Project

Deer Horn is located on 51.33 square kilometers (km) in west-central British Columbia, 36 km south of the prolific Huckleberry copper-molybdenum mine and 135 km southwest of the community of Burns Lake. It is one of few significant tellurium discoveries outside Asia and includes a 2.4 km-long vein system of high-grade gold, silver and tellurium, as well as broader zones of bulk-tonnage gold, silver and tellurium mineralization. The company completed a positive Preliminary Economic Estimate and has begun permitting for a 10,000-tonne bulk sample program to advance the project toward mine feasibility. It is North America’s only silver-gold-tellurium property with an NI 43-101 compliant tellurium resource, and it hosts a number of other mineralized targets and zone containing critical metals such as copper, tungsten and zinc.

First Tellurium owns 50% of the property, with an option to acquire up to a 75% interest. The company has engaged Dias Geophysical of Saskatoon, Saskatchewan, to conduct induced polarization (IP) geophysics on the Deer Horn Project in summer 2023. The program is designed to help develop drill targets for a subsequent drilling program.

Klondike Gold-Tellurium Project

The Klondike property is located in Saguache County, Colorado, southwest of Buena Vista in the state’s historical mining district. The company reports it has engaged Burgex Mining Consultants of Sandy, Utah, to stake additional claims around the Klondike property. The claims have been filed with the Bureau of Land Management.

Klondike demonstrates exceptional tellurium grades. Tellurium, used in high-efficiency cadmium telluride (Cd-Te) solar panels, next-generation lithium-ion batteries and thermoelectric devices to change heat into energy, is an essential element for the world’s transition to green energy.

The Klondike property was a top tellurium prospect owned previously by First Solar Inc., one of the world’s largest solar panel producers. First Solar terminated its worldwide raw materials exploration program in 2012 and sold the property to Colorado Klondike LLC, which optioned the project to First Tellurium. Colorado Klondike, led by First Solar’s former Exploration Manager in North America, is managing the upcoming exploration program.

The Colorado Geological Survey (CGS), in partnership with the Colorado School of Mines, reported on First Solar’s exploration at Klondike in 2015, noting: “Surface sampling by First Solar, Inc. in 2006 found very high tellurium grades of up to 3.3% (33,000 ppm), along with locally high gold grades. Tellurium grades at Klondike were the highest encountered in the company’s nationwide exploration program.”

Market Outlook

First Tellurium in spring 2023 referenced recent forecasts by the International Energy Agency (IEA) pointing to rapid growth in solar photovoltaic (solar PV) deployment worldwide. According to the agency, solar PV installations will generate more power by 2027 than any other energy source, including coal, natural gas and hydro. To meet this demand, consumption of both silver and tellurium, key components of solar panels, is expected to surge in coming years.

Chen Lin, founder of Lin Asset Management, has written in his investment newsletter for clients that solar PV is now the largest industrial usage of silver. He said that in 2022 solar PV production used about 12% of total silver demand, or about 120 million ounces of silver. Lin expects this number to rise dramatically in the coming years, and that is likely to lead to silver supply deficits for decades to come.

Lin points out that solar power is now the cheapest source of energy in many parts of the world and that all forecasts point to dramatic expansion of solar PV in the coming two decades. Conservative estimates forecast 300 gigawatts of solar PV production by 2027, up from the current level of about 200 gigawatts.

Management Team

Tyrone Docherty is President, Director and CEO of First Tellurium Corp. He previously served as President and CEO of Quinto Mining Inc., taking over when it had a market cap of $4 million. With limited resources in a difficult market environment, he raised more than $30 million and advanced Quinto’s Quebec iron ore property to a viable project. Quinto later sold for $175 million, with Quinto management taking shares of the purchaser, Consolidated Thompson Iron Mines, amounting to approximately 20-21% of that company. Consolidated Thompson Iron Mines sold two years later for $4.9 billion, giving the former Quinto team an enterprise value of approximately $1 billion. From 2012 to 2018, Mr. Docherty was Director and Chairman of Mason Graphite Inc. He has worked in the financial and minerals markets for more than 30 years.

Tony Fogarassy, M.Sc. LL.M., is Chairman of First Tellurium Corp. He is a lawyer and a geologist. His extensive legal and technical expertise includes minerals, oil and gas, coal and renewable energy projects and environmental and aboriginal/indigenous law in North America, Africa and Asia. He graduated as gold medalist in geological sciences from the University of British Columbia and in law from the London School of Economics.

First Tellurium Corp. (OTCQB: FSTTF), closed Wednesday's trading session at $0.0895, off by 4.2781%, on 39,150 volume. The average volume for the last 3 months is 95,646 and the stock's 52-week low/high is $0.047785/$0.1046.

Recent News

ECGI Holdings Inc. (OTC: ECGI)

The QualityStocks Daily Newsletter would like to spotlight ECGI Holdings Inc. (OTC: ECGI).

ECGI Holdings Inc. (OTC: ECGI) is a diversified holding company with a distinctive portfolio encompassing viticulture and luxury fashion. The company owns and manages a five-acre vineyard in Lake County, California, specializing in cultivating the Petite Sirah varietal, known for its bold and rich character, aligning with the growing demand for unique and high-quality wine experiences.

In the fashion sector, ECGI has strategically invested in Pacific Saddlery, a premier manufacturer and retailer of luxury equestrian tack, apparel and accessories. This unique blend of wine and fashion investments reflects ECGI Holdings’ commitment to delivering sophistication and innovation across diverse markets, positioning the company as a distinctive player in the intersection of technology, viticulture and luxury lifestyle.

Moving forward, ECGI Holdings is focused on identifying and capitalizing on growth opportunities that align with the company’s business objectives and continuing to improve its financial structure. In 2024, ECGI Holdings was approved by Evolve — a distinguished name in vacation rental management. This partnership will transform the company’s 40-acre Lake County property into a luxurious short-term rental destination aptly named Vintner’s Caldera Ranch.

ECGI Holdings is excited about the possibilities that Vintner’s Caldera Ranch creates for shareholders and looks forward to further developments poised to unlock the value of other underutilized assets. The company believes that it is laying a solid foundation for sustained success and profitability in the years to come.

ECGI Holdings is headquartered in Irvine, California.

Operational Philosophy

ECGI Holdings has embarked on an ambitious new vision and strategic direction to build and nurture luxury brands that resonate with its core values and market aspirations. Its joint venture with Pacific Saddlery epitomizes ECGI Holdings’ strategic shift toward luxury branding, leveraging Pacific Saddlery’s tangible and established market presence in equestrian products.

This transition will also allow ECGI Holdings to explore new pathways to monetize its underutilized assets, including the company’s vineyard. A key highlight of the company’s future outlook is the debut of Pacific Saddlery’s new mobile retail boutique at specific equestrian events in 2024. This innovative venture represents a significant step in ECGI Holdings’ strategy to enhance brand visibility and engage directly with the company’s target market.

In addition, the Vintner’s Caldera Ranch development marks a significant step in advancing the company’s strategy to revitalize and leverage underutilized assets. Vintner’s Caldera Ranch is set against the backdrop of Lake County’s breathtaking scenery, offering an exclusive getaway experience that blends natural beauty with luxury. Choosing Evolve is a strategic move to ensure that Vintner’s Caldera Ranch not only meets but exceeds the high standards of service that luxury guests expect.

Evolve’s expertise in maximizing rental potential and delivering exceptional guest experiences is crucial to the company’s vision of making Vintner’s Caldera Ranch a preferred choice for discerning travelers. With this venture, ECGI Holdings is not only expanding its footprint within the luxury rental marketplace, but also contributing to the local economy and enhancing the appeal of Lake County as a tourist destination.

The company’s focus remains steadfast on strategic growth, operational excellence and customer satisfaction.

Market Outlook

A report from Grand View Research, a global market research and consulting company, estimated the value of the worldwide luxury brands market at $366.23 billion in 2023 and projects the market to grow to a value of $580.43 billion by 2030, achieving a CAGR of 6.8% over the forecast period.

Rising disposable income and wealth in various regions of the world, particularly in emerging markets such as China and India, have propelled the growth of the market, according to the report.

Younger consumers, such as millennials and Generation Z, are increasingly entering the luxury market, driving demand for more contemporary and experiential luxury offerings. The rise of social media and influencer marketing has greatly impacted the visibility and desirability of luxury products, the report states.

Management Team

Jamie Steigerwald is CEO of ECGI Holdings, Inc. He is a successful entrepreneur with over 30 years of experience. Most recently, he was COO of Sugarmade Inc. (OTC: SGMD), a California cannabis real estate, cultivation, manufacturing and services company. He is the owner of SwiftLead, an Orange County web marketing, design and development company. He previously was COO for First USA Home Loans, a retail mortgage lender, and co-founder and President of SwiftLead Software, a mortgage lead tracking system.

Nick Collins is CEO at Pacific Saddlery. He brings over 25 years of expertise in equestrian luxury goods. He previously founded Rolling Meadows and created the Allon Equestrian and Renard et Cheval apparel brands. He was instrumental in creating and launching Kaval.com, an online equestrian apparel and accessories site.

ECGI Holdings Inc. (OTC: ECGI), closed Wednesday's trading session at $0.0029, even for the day. The average volume for the last 3 months is 653,234 and the stock's 52-week low/high is $0.0016/$0.015.

Recent News

Nutriband Inc. (NASDAQ: NTRB)

The QualityStocks Daily Newsletter would like to spotlightFathom Nutriband Inc. (NASDAQ: NTRB) .

Nutriband Inc. (NASDAQ: NTRB) is engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s AVERSA™ technology can be incorporated into any transdermal patch and includes aversive agents to prevent abuse, diversion, misuse and accidental exposure to drugs with abuse potential, specifically opioids.

AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico and Australia.

The company’s business model is to apply its transdermal technology to existing FDA-approved drugs with a goal of improving safety, efficacy and patient comfort while qualifying for a limited-development regulatory pathway that reduces the number of clinical trials required for approval of new drugs.

Nutriband has three subsidiaries, including 4P Therapeutics, its clinical and regulatory subsidiary; Pocono Pharmaceutical, a contract manufacturer for a wide range of clients; and Active Intelligence, a developer of sports recovery products. This ownership of manufacturing and clinical development capabilities drastically reduces costs for AVERSA and other technologies.

In April 2024, Nutriband announced that the company had been engaged by and received a first order from Fit For Life Group, a major brand license holder. A fully executed supplier agreement is expected to follow. Nutriband’s wholly owned Active Intelligence subsidiary will act as manufacturer.

The company is headquartered in Orlando, Florida.

Products

Nutriband’s lead product candidate is AVERSA Fentanyl, an abuse-deterrent fentanyl transdermal patch. The company announced in March 2024 that it will submit a New Drug Application to the U.S. Food and Drug Administration seeking approval to market AVERSA Fentanyl.

Nutriband has partnered with Kindeva Drug Delivery, a leading global contract development and manufacturing organization, to incorporate Nutriband’s AVERSA abuse-deterrent transdermal technology into Kindeva’s FDA-approved transdermal fentanyl patch system. Because Nutriband’s abuse-deterrent technology is incorporated into the fentanyl patch but is physically separate from and does not come in contact with the drug layer, the clinical trials typically needed to demonstrate safety and efficacy for a new drug formulation would not be required.

AVERSA Fentanyl has the potential to be the first and only abuse deterrent patch approved anywhere in the world. The company plans to seek an expedited review by the FDA, as has been granted for certain abuse-deterrent oral opioid products, which shortens the regulatory review period to six months from the conventional 10-month FDA review cycle for NDAs.

Nutriband’s AVERSA product development pipeline also includes abuse deterrent versions of currently approved and marketed transdermal patches containing buprenorphine, an opioid used to treat opioid use disorder, and methylphenidate, a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD). Both are labeled with FDA-required warnings for the risk of abuse and misuse, as well as warnings against accidental exposure.

Market Opportunity

Nutriband cites a market analysis report from Boston-based Health Advances, a healthcare and life sciences consulting firm. According to the report, upon FDA approval, AVERSA Fentanyl has the potential to reach peak annual sales of $200 million in the U.S.

The company further states that, should non-abuse-deterrent transdermal fentanyl products lose FDA marketing approval, AVERSA Fentanyl would have greater pricing flexibility and would have the potential to generate more than $500 million in annual revenue.

Management Team

Gareth Sheridan is Co-Founder and CEO of Nutriband. He was Ireland’s ‘Young Entrepreneur of the Year’ in 2014 for establishing Nutriband. He has worked as a Business Mentor with 100 Minds, a social enterprise that brings together some of Ireland’s top college students and connects them with a cause to achieve large charitable goals. He received a B.Sc. in Business and Management from Dublin Institute of Technology.

Serguei Melnik is Co-Founder and President of Nutriband. He has been involved in general business consulting for companies in the U.S. financial markets and setting up legal and financial frameworks for operations of foreign companies in the U.S. He previously was the COO of Florida-based Asconi Corporation. He also was a lawyer in the Department of Foreign Affairs, JSC Bank “Inteprinzbanca,” in Chisinau, Moldova, and prior to that practiced law in Moldova. He is fluent in four languages.

Jeff Patrick, Pharm.D., is Chief Scientific Officer of Nutriband. He currently serves as Director of the Drug Development Institute at the Ohio State University Comprehensive Cancer Center. His prior roles included Global Vice President at Mallinckrodt Pharmaceuticals Inc.; and roles at Dyax, Myogen/Gilead, Actelion and Sanofi-Synthelabo Inc. He was a clinical pharmacist at the University of Tennessee Medical Center and a clinical assistant professor of pharmacy at the University of Tennessee College of Pharmacy.

Gerald Goodman is CFO of Nutriband. He is a certified public accountant with his own firm, Gerald Goodman CPA. He also practiced with Madsen & Associates, CPAs, and was a partner in the accounting firm of Wiener, Goodman & Company. He is also a director of Lifestyle Medical Network Inc., which provides management services to healthcare providers. He is a graduate of Pennsylvania State University, where he received a bachelor’s degree in accounting.

Nutriband Inc. (NASDAQ: NTRB), closed Wednesday's trading session at $9.25, up 19.509%, on 127,641 volume. The average volume for the last 3 months is 35,777 and the stock's 52-week low/high is $1.53/$9.595.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.